HemoGenyx Pharmaceuticals Plc
LLSE:HEMOLatest Stock Split
Dec 13, 2024
1:400
For every 400 shares held, investors received 1. The price per share adjusted from $1.07 to $430.00.
The split itself did not change the total investment value.
Use this split data in your app
Build with our dataStock Split History
- Dec 13, 2024Before$1.07Split ratio1:400After$430.00Reverse
About HemoGenyx Pharmaceuticals Plc stock splits
HemoGenyx Pharmaceuticals Plc (LSE:HEMO) operates in the Biotechnology industry.
HemoGenyx Pharmaceuticals Plc company overviewWhen did HemoGenyx Pharmaceuticals Plc stock split?
HemoGenyx Pharmaceuticals Plc's most recent stock split was on December 13, 2024. It was a 1-for-400 reverse split, so shareholders received 1 share for every 400 they held.
How many times has HemoGenyx Pharmaceuticals Plc stock split?
HemoGenyx Pharmaceuticals Plc has split its stock once. This history records one reverse split, on December 13, 2024.
What is a reverse stock split?
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In HemoGenyx Pharmaceuticals Plc's 1-for-400 reverse split on December 13, 2024, every 400 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Will HemoGenyx Pharmaceuticals Plc split its stock again?
HemoGenyx Pharmaceuticals Plc has not announced a new split in our records. Its most recent split was on December 13, 2024, 1 year ago. Companies announce splits in advance, and any new LSE:HEMO split will appear on this page.